129 related articles for article (PubMed ID: 396068)
1. Does the renin-angiotensin system maintain blood pressure in both hypertensive and normotensive subjects? A comparison of propranolol, saralasin and captopril.
MacGregor GA; Markandu ND; Roulston JE
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():145s-148s. PubMed ID: 396068
[No Abstract] [Full Text] [Related]
2. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
3. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
Zawada ET; Stinson J; Ramirez G
Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
[TBL] [Abstract][Full Text] [Related]
4. Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system.
McCaa RE
Prog Biochem Pharmacol; 1980; 17():29-35. PubMed ID: 7010367
[TBL] [Abstract][Full Text] [Related]
5. Hypotensive action of captopril and saralasin in intact and anephric spontaneously hypertensive rats.
Hutchinson JS; Mendelsohn FA; Doyle AE
Hypertension; 1980; 2(2):119-24. PubMed ID: 6991407
[TBL] [Abstract][Full Text] [Related]
6. [Effects of a single dose of captopril on blood pressure and the renin-angiotensin-aldosterone system in normal subjects and hypertensive patients with various etiologies (author's transl)].
Ogihara T; Maruyama A; Mikami H; Naka T; Higaki J; Kanda T; Gotoh M; Hata T; Kumahara Y
Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1185-92. PubMed ID: 396402
[No Abstract] [Full Text] [Related]
7. Antihypertensive effects of angiotensin blockade: saralasin versus captopril.
Baker KM; Johns DW; Vaughan ED; Ayers CR; Carey RM
Clin Exp Hypertens (1978); 1980; 2(6):947-54. PubMed ID: 7004807
[No Abstract] [Full Text] [Related]
8. Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension.
Case DB; Atlas SA; Laragh JH
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():313s-316s. PubMed ID: 232024
[TBL] [Abstract][Full Text] [Related]
9. Captopril in hypertension with renal artery stenosis and in intractable hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I and II and aldosterone, and in body composition.
Atkinson AB; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():139s-143s. PubMed ID: 396067
[No Abstract] [Full Text] [Related]
10. Circulatory effects of renin-angiotensin system antagonists during halothane anaesthesia in hypertensive rats.
Kaukinen S; Kataja J; Ylitalo P
Acta Anaesthesiol Scand; 1983 Feb; 27(1):81-6. PubMed ID: 6340406
[TBL] [Abstract][Full Text] [Related]
11. Captopril compared with other antirenin system agents in hypertensive patients: its triphasic effects on blood pressure and its use to identify and treat the renin factor.
Laragh JH; Case DB; Atlas SA; Sealey JE
Hypertension; 1980; 2(4):586-93. PubMed ID: 6156900
[No Abstract] [Full Text] [Related]
12. Haemodynamic effects of captopril in hypertensive patients: comparison with saralasin.
Fagard R; Amery A; Lijnen P; Reybrouck T
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():131s-134s. PubMed ID: 396066
[TBL] [Abstract][Full Text] [Related]
13. Renin, renin substrate, angiotensin II, and vasopressin in plasma during treatment with captopril in hypertension and heart failure.
Fyhrquist F; Forslund T; Immonen I; Tikkanen I; Grönhagen-Riska C; Hortling L
Acta Med Scand Suppl; 1983; 677():110-4. PubMed ID: 6367370
[No Abstract] [Full Text] [Related]
14. Haemodynamic profile of angiotensin II antagonism in essential hypertensive patients.
Hunyor SN; Larkin H; Rowe J
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():119s-121s. PubMed ID: 396063
[TBL] [Abstract][Full Text] [Related]
15. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
Pettinger WA; Mitchell HC
N Engl J Med; 1975 Jun; 292(23):1214-7. PubMed ID: 236513
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effects of captopril and saralasin in essential and renal hypertension.
Konrads A; Meurer KA; Hummerich W; Wambach G; Kindler J; Feltkamp H; Helber A
Am J Cardiol; 1982 Apr; 49(6):1558-60. PubMed ID: 7041597
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of an angiotensin-II analog and a converting enzyme inhibitor.
Fagard RH; Amery AK; Lijnen PJ; Reybrouck TM
Kidney Int; 1980 May; 17(5):647-53. PubMed ID: 6249956
[TBL] [Abstract][Full Text] [Related]
18. Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition.
Johnston CI; Clappison B; McGrath BP; Matthews PG; Millar JA; Anderson WP
Prog Biochem Pharmacol; 1980; 17():123-33. PubMed ID: 6259649
[No Abstract] [Full Text] [Related]
19. The effects of captopril, propranolol, and indomethacin on blood pressure and plasma renin activity in spontaneously hypertensive and normotensive rats.
Antonaccio MJ; Harris D; Goldenberg H; High JP; Rubin B
Proc Soc Exp Biol Med; 1979 Dec; 162(3):429-33. PubMed ID: 390537
[No Abstract] [Full Text] [Related]
20. Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat.
Marks ES; Bing RF; Thurston H; Swales JD
Clin Sci (Lond); 1980 Jan; 58(1):1-6. PubMed ID: 6986224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
